Deguelin inhibits proliferation and migration of human pancreatic cancer cells in vitro targeting hedgehog pathway.
Deguelin inhibits proliferation and migration of human pancreatic cancer cells in vitro targeting hedgehog pathway.
复制标题
DOI:
10.3892/ol.2016.4928
复制
发表时间:
2016-10
期刊:
影响因子:
2.9
通讯作者:
Wen Zheng;Shiliu Lu;Haolei Cai;Muxing Kang;W. Qin;Chao Li;Yulian Wu
中科院分区:
文献类型:
--
作者:
Wen Zheng;Shiliu Lu;Haolei Cai;Muxing Kang;W. Qin;Chao Li;Yulian Wu
Pancreatic cancer (PC) is a highly lethal malignancy with few effective therapies. Deguelin, a natural compound of the flavonoid family of products, has been reported to have an inhibitory effect on various cancers. In the present study, we investigated whether deguelin had antitumor efficacy in PC. Deguelin treatment was observed to inhibit growth and induce apoptosis in two PC cell lines (Bxpc-3 and Panc-1). In addition, it inhibited migration and invasion in these two cell lines. The activation of the hedgehog (Hh) signaling pathway, as well as matrix metalloproteinases (MMP)-2 and MMP-9, was suppressed by deguelin. These results suggest that deguelin may be a potential chemotherapeutic agent for PC, possibly through the suppression of the Hh signaling pathway.